Wendy Wang

National Cancer Institute

Papers

3

Total Citations

71

H-Index

3

About

Wendy Wang is a pioneering researcher in the field of cancer diagnostics, with a focused expertise in telomerase biology and its clinical applications for early cancer detection. Her work centers on developing and validating analytical methods to measure telomerase activity—an enzyme expressed in 85-90% of human cancers but absent in normal somatic tissues—as a noninvasive biomarker for cancer screening. Wang’s major contributions include the analytical validation of telomerase activity assays for early cancer detection (30 citations), the development of high-throughput capillary electrophoresis methods for telomerase analysis (23 citations), and the preparation of candidate reference materials to standardize telomerase assays (18 citations). These foundational studies have established critical frameworks for translating telomerase detection from research laboratories into practical, cost-effective clinical tests using easily obtained body fluids. Her work on reference materials, in particular, addresses a key challenge in assay reproducibility and comparability across studies. With cumulative citations reflecting the growing interest in liquid biopsy approaches, Wang’s research has significantly advanced the potential for noninvasive cancer screening, offering hope for earlier diagnosis and improved patient outcomes.

Research Focus

Key Achievements

3
H-Index
3
Papers
71
Total Citations
24
Avg Citations/Paper
🏆 Most Cited Paper
Analytical Validation of Telomerase Activity for Cancer Early Detection
30 citations · 2004
📈 Most Prolific Year: 2004 (1 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: National Cancer Institute

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago